10^-4 eV
11
-0.7
The ones related to the circulation of the electric field and the divergence of the magnetic field.  
(\cos(\theta/2), \sin (\theta/2))

E = (2n_x+n_y+3/2)ℏ*sqrt(k/m)
2.6*1e5 GeV
G2 is a transcription factor, G1 and G3 show gene redundancy, G1 is epistatic towards G3
triphenyleno[1,2-c:5,6-c':9,10-c'']trifuran-1,3,6,8,11,13-hexaone
c
SARS-CoV-2 nsp10/nsp14-ExoN operates as heterodimers in a mismatch repair mechanism. The N-terminal ExoN domain of nsp14 could bind to nsp10 making an active exonuclease complex that prevents the breakdown of dsRNA. 
4.12 MeV, 29.8 MeV
(1S,2S,4R)-4-isopropyl-2-methoxy-1-methylcyclohexyl propionate
At active promoters and enhancers
Planet_1 is preferred due to its ~1.65 times higher probability to transit.

3
6.3x10^-7 M
~12.6
A = methyl 1-(2-((2,4-dimethylphenyl)sulfinyl)ethyl)-2-oxocyclohexane-1-carboxylate, B = ethyl 2-ethyl-2-(1-(2-methoxy-2-oxo-1-phenylethyl)cyclopentyl)butanoate
1,2,4
A = benzoquinone, B = methyl 2-hydroxypropanoate
weaker - slower
3,3,4-trimethylchromane and 3-isopropyl-3-methyl-2,3-dihydrobenzofuran
18
A = 2,7-dimethyloctahydronaphthalene-4a,8a-diol, B = (((3-methylbut-2-en-1-yl)oxy)methyl)benzene
A = 2,2-diiodoethen-1-one, B = 3, 1, 2, 4
cytosol to the extracellular space
(2S,3R,4S,6S)-2-benzyl-4-hydroxy-6-methyl-3-phenylcyclohexan-1-one
Mutant 2
Red
c2h
20.132 GeV
(3aR,4R,7S,7aS)-4,7-dimethyl-3a,4,7,7a-tetrahydro-4,7-epithioisobenzofuran-1,3-dione
A = 3-ethyl-3-phenylpentan-2-one, B = 3-(4-hydroxyphenyl)-3-phenylpentan-2-one, C = 2,2,2-tris(4-methoxyphenyl)-1-phenylethan-1-one
The eigenfunction of the operator Ay can also be an eigenfunction of A^2, but not of the Z-component, Az.
Cold atomic interstellar medium.
3
A = (i) LDA, DME (ii) CH3CH2I (iii) H3O+ B = heptan-4-one
0.85
The compounds they are working with have similar polarities.
(1+n*v)/(n+v)


~ 33.4
3-cyano-6-(dimethylamino)-5-formyl-2-hydroxy-4-methoxybenzoic acid
Differential centrifugation extraction of mitochondria followed by the Glucose Uptake Colorimetric Assay Kit 
10E, 15E, 18E

6
ethyl 4-aminobenzoate
6
A = (Z)-1-(but-2-en-2-yloxy)ethen-1-amine, B = (3Z,4E)-3,4-diethylidenecyclobut-1-ene, C = 4-methylenehexanal
3
U=- (1/2) *kq^2 R/(d^2 -R^2)
~4.5
C11H12O2
5-isopropyl-3,4-dimethylocta-1,7-diene
Trans-propenyl acetate
|3,0,0\rangle\rightarrow|2,1,0\rangle\rightarrow|1,0,0\rangle and \frac{1}{3}
251.271 fm

Superstring Theory
12.62
81 years
3-bromo-4'-methoxy-1,1'-biphenyl
1. NaNH2, methyl chloride
2. H2/Pd-calcium carbonate
3. O3/ (CH3)2S
4. Ba(OH)2
p = 1.4*10^(-28) N*s
17
A = (E)-bicyclo[5.3.1]undec-1(11)-en-4-one, B = lithium 3-ethylpent-4-enoate
1,2,4
0
gamma*B
2.08*1e-6 m
C2v
~0.83
4
v_rel = 0.14c , E= 5.96 mc^2
44%
The ribosome terminated the translation early
cytoplasmic localization of the red signal
A = 4-methyl-1-phenylpent-3-en-1-ol, B = 2,3,4,6,7,8-hexamethyl-5,9,10,11-tetrahydro-1H-benzo[3,4]azuleno[1,8,7,6-cdef]fluorine
V(\vec{r},t) = \dfrac{qc}{4\pi\epsilon_o (d c - \vec{d}. \vec{v})},  \vec{A(\vec{r},t)} = \dfrac{\mu_o qc \vec{v}}{4\pi (d c - \vec{d}. \vec{v})}
2-(4-methylstyryl)oxirane
315
1. Zn, ether
2. Cl2/hv
3. Aq. KOH
4. Pyridine + CrO3 + HCl
5. Aq. NaOH
name: dimethyl (1R,4S,4aS,4bR,5S,8R,8aS,8bR,10S,11R)-1,4,4a,4b,5,8,8a,8b-octahydro-1,4-ethano-5,8-methanobiphenylene-10,11-dicarboxylate

SMILES: O=C(OC)[C@H]1[C@@H](C=C2)[C@@H]3[C@@H]([C@@H]4[C@H]3[C@@H]5C=C[C@H]4C5)[C@@H]2[C@H]1C(OC)=O
4.26; 8.52
Linear partial fraction of fractional approximation
~ 0.53
A = (S)-3-ethyl-5-isobutoxy-5-oxopentanoic acid , B = (S)-3-ethyl-5-isobutoxy-5-oxopentanoic acid
1H NMR: chemical reference (ppm): 7.8 (2H, d), 7.6 (2H, d), 2.3 (3H, s)
somatic hypermutation
triplet of triplets
3,4-dimethyl-5,6-dioxooctanoic acid
((R)-((R)-2,2-difluorocyclohexyl)fluoromethyl)benzene
11.44 kJ/g
Ct values are not in agreement with the amount of target nucleic acid in samples 
methyl (2E,8E,10E)-tetradeca-2,8,10-trienoate
6-hydroxy-2,2,5,5-tetramethyloctan-4-one
10^62 J/K
chromatin methylation by histone methyltransferases in the post-zygote
bicyclo[3.2.0]hept-6-ene
CH3C(H)(C2H5)C(H)(C2H5)CH2COOH
H gives a yellow color with the addition of ferric chloride solution.
A = cyclohexanecarbaldehyde, B = TsOH
the receptor and the eGFP are not in the frame
i) HNO3/H2SO4 ; ii) Fe/HCl ; iii) CH3COCl/AlCl3 ; iv) Br2/FeBr3 ; v) HNO3/H2SO4 ; vi) NaNO2/HCl ; vii) H3PO2
~ 0.36
~0.32
A = TsOH, B = 3-(2-oxocyclohexyl)propanal
Combine in silico predictions with preliminary in vitro binding affinity assays to validate the most promising forms of Xantheraquin before extensive docking studies.
\left\langle H\right\rangle \ll\Delta E
1S0 -> 3P0 + s
Star3 and Star5
A = ethyl 3-(3-ethyl-1,3-dimethyl-2-oxocyclohexyl)propanoate, B = 3-methyl-4-nitrohexanenitrile
0.64, 0.36 and hbar / 7
C6H10O2
A = NaHSO3, B = HCl
138
(1S,4R,5S,6S)-4,5,6-trimethylcyclohex-2-enol
1 and 2
2-bromo-4,4-dimethylcyclopentanone
3a,4,5a-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene
~ 1/plx^4
(1R,2R,4R,5R)-1,2,4,5-tetramethylcyclohexan-1-ol 
8
3 060 000 km.
54
(9/2) \hbar \omega , 10
5 Peaks in chiral HPLC and 4 peaks in normal-phase HPLC
4-ethyl-3-methyldeca-1,5-diene
ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCGCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCGTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCCGCATGCCAGAGGCTGCTCCCCCCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGCGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTCCTGGGCGCGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCGCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGACTGA
3,4-dimethylcyclohexan-1-one
1.9


A 1H doublet at ~1.5 ppm and a 2H singlet at ~3.5 ppm
1,2,4,5-tetramethylbenzene and 1,2,3,4-tetramethylbenzene
6.24x10^-7 M
-2.72 kcal
X\rightarrow c\bar{c},s\bar{s},u\bar{u},d\bar{d},\tau^{+}\tau^{-},\mu^{+}\mu^{-},e^{+}e^{-}
4 π
3536
The increased pH of the solution
A = 4-isopropylcyclohexan-1-one, B = 5-methylhexan-2-one
35
3
r=(0,0,0)
A = 1-(hydroxydi-p-tolylmethyl)cyclopentan-1-ol, B = methyl 3-oxo-2-(p-tolyl)butanoate
4.0655 * 10^-15 m
16
(3aR,4R,7S,7aS,8r)-8-fluoro-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione
0.77c
110-130
The crude compound exists as a mixture of diastereoisomers
2,4-bis(4-hydroxyphenyl)but-2-enal
1/3

pre-replication complex
A = trimethyl 2-(p-tolyl)propane-1,1,3-tricarboxylate, B = 3-(2-oxocyclohexyl)butanenitrile, C = cyclohexane-1,3-dione
4-chlorobenzoic acid
\hbar/\sqrt{2}

2 peaks in standard HPLC and 3 peaks in chiral HPLC
First you identify the virus by performing cDNA sequencing.  You then develop a real time PCR kit for quick and accurate diagnosis.
protein aggregation and loss-of-function phenotype
8 Gpc
0.506 \lambda / a
λ2 < λ1
+\infty
pH 2.69; 30.09 cm3
~ 0.4
One can use a catalyst of a group VIa transition metal in combination with specific activators.
M_{h_{2}}^{2}=\frac{1}{8\pi^{2}\left(x^{2}+v^{2}\right)}\left\{ \alpha_{1}M_{h_{1}}^{4}+\alpha_{2}M_{W}^{4}+\alpha_{3}M_{Z}^{4}-\alpha_{4}M_{t}^{4}+\alpha_{5}M_{H^{\pm}}^{4}+\alpha_{6}M_{H^{0}}^{4}+\alpha_{7}M_{A^{0}}^{4}-\alpha_{8}\sum M_{N_{i}}^{4}\right\} 
1.38
3 and 4
The spectrum remains continuous with an adjusted shape, and the endpoint increases.
-12*hbar/25


4<6<2<1<5<3
ln(2) = [ (T_1 - T_2) / (T1*T2)]

~10^(-16) J
5 MeV.
3/4, \lambda^(-6)
1/6
~2.23

The mass dimension \left[\kappa\right]_{M}=-1. The theory is not renormalizable.
(e^X)*Y*(e^{-X}) represents a quantum state.
2.822 x 10^-26
0.01 (10^-2).
The Mott-Gurney equation is valid for a trap-free single-carrier device with no carrier injection barrier and negligible diffusion current.
1
i) tert-butyl chloride/AlCl3 ; ii) SO3/H2SO4 ; iii) HNO3/H2SO4 iv) Fe/HCl ; v) NaNO2/HCl ; vi) HNO3/H2SO4 ; vii) H3O+, H2O/Heat ; viii) dilute H2SO4 ix) NaOH/EtBr
+ \varepsilon, -\varepsilon

4,4a,7,7a-tetrahydro-1H-cyclopenta[c]pyridine
3
9.54 Angstrom
Skyrmion
5, 2, 1, 3 and 4
(3-isopropylcyclohexyl)methanol
$E = \dfrac{1}{4 \pi \epsilon_o} \dfrac{q}{L^2}$

~ r^3
Z= 2 e^(3J\beta)+6e^(-J\beta)
~ 33.5
$v_{max}=c\sqrt{1-\frac{1}{(1+\frac{kA^2}{2mc^2})^2}}$
1-(sec-butyl)-4-methylbenzene
16.9%
